Best Medical Treatment: What About the COMPASS Trial Strategy?

Authors

  • Sofia Rosado Julião Serviço de Medicina III. Hospital Pulido Valente. Centro Hospitalar e Universitário de Lisboa Norte. Lisboa. https://orcid.org/0000-0002-1727-1101
  • Andreia Rodrigues Lopes Serviço de Medicina III. Hospital Pulido Valente. Centro Hospitalar e Universitário de Lisboa Norte. Lisboa.
  • Mariana Alves Serviço de Medicina III. Hospital Pulido Valente. Centro Hospitalar e Universitário de Lisboa Norte. Lisboa. Faculdade de Medicina. Universidade de Lisboa. Lisboa. https://orcid.org/0000-0002-1369-8423

DOI:

https://doi.org/10.20344/amp.18879

Keywords:

Aspirin/therapeutic use, Coronary Artery Disease/drug therapy, Platelet Aggregation Inhibitors/therapeutic use, Peripheral Arterial Disease/drug therapy, Rivaroxaban/therapeutic use

Abstract

N/a.

Downloads

Download data is not yet available.

Downloads

Published

2022-08-18

How to Cite

1.
Rosado Julião S, Rodrigues Lopes A, Alves M. Best Medical Treatment: What About the COMPASS Trial Strategy?. Acta Med Port [Internet]. 2022 Aug. 18 [cited 2023 Feb. 7];35(10):777-8. Available from: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/18879

Issue

Section

Letters to the Editor